Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
CELGENE CORP Add to My Watchlist (NSDQ: CELG) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Celgene Corp 55.50 +0.73 (+1.33%) 2,926,769
86 Morris Avenue
Summit, NJ 07901 US
(908) 673-9000
(908) 673-9001 fax
www.celgene.com
CEO Dr. Sol J. Barer, Ph.D.
Auditor KPMG LLP
Exchange Traded NQ
ISIN Number US1510201049
CIK Number 816284
NAICS Code 325412
Business Summary
A biopharmaceutical company, which is engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
Number of Employees 2,441
Share Fundamentals
Market Cap 25.51B
Shares Outstanding 459.60M
Float 457.03M
Short Interest 8.59M
Financial Strength
Revenue (TTM) $2,689,893,000
Earnings (TTM) $776,747,000
Quick Ratio 6.5:1
Current Ratio 7.1:1
Total Debt/Equity 0:1
Profitability
Gross Margin 92.7%
EBITDA Margin 22.2%
Profit Margin 22.3%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs